Currently, Blue Star is trading at 60 times its FY26 estimated earnings, well above its five-year average PE ...

Biocon shares rose 9% to ₹389, driven by positive developments including Japanese approval for its biosimilar Ustekinumab.

Ahead of the quarterly results season, brokerage house Motilal Oswal has given a 'buy' rating to Titan Stock.In its report ...

Shares of foodtech major Zomato dipped as much as 4.9% from yesterday’s (January 6) close to INR 251.60 during ...